[Combination therapy of bisphosphonate and estrogen for osteoporosis].
Ohta
Hiroaki
H
Department of Obstetrics and Gynecology, Tokyo Women's Medical University.
D019386:Alendronate / Q000627:therapeutic use; D015519:Bone Density; D004164:Diphosphonates / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use*; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005272:Femur Neck / Q000503:physiopathology; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D000068296:Risedronic Acid; D013131:Spine / Q000503:physiopathology
D004164:Diphosphonates; D004967:Estrogens; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate